Clinical Picture and Risk Factors of Severe Respiratory Symptoms in COVID-19 in Children

Autor: Jowita Rosada-Kurasińska, Magdalena Figlerowicz, Zuzanna Lewandowska, Katarzyna Mazur-Melewska, Agnieszka Cwalińska, Alicja Bartkowska-Śniatkowska, Katarzyna Jończyk-Potoczna, Karol Lubarski, Kamil Faltin, Paweł Małecki, Anna Mania
Rok vydání: 2021
Předmět:
Zdroj: Viruses
Viruses; Volume 13; Issue 12; Pages: 2366
Viruses, Vol 13, Iss 2366, p 2366 (2021)
ISSN: 1999-4915
Popis: Children with COVID-19 develop moderate symptoms in most cases. Thus, a proportion of children requires hospital admission. The study aimed to assess the history, clinical and laboratory parameters in children with COVID-19 concerning the severity of respiratory symptoms. The study included 332 children (median age 57 months) with COVID-19. History data, clinical findings, laboratory parameters, treatment, and outcome, were evaluated. Children were compared in the groups that varied in the severity of symptoms of respiratory tract involvement. Children who required oxygen therapy represented 8.73%, and intensive care 1.5% of the whole cohort. Comorbidities were present in 126 patients (37.95%). Factors increasing the risk of oxygen therapy included comorbidities (odds ratio (OR) = 92.39; 95% confidence interval (95% CI) = (4.19; 2036.90); p < 0.00001), dyspnea (OR = 45.81; 95% CI (4.05; 518.21); p < 0.00001), auscultation abnormalities (OR = 34.33; 95% CI (2.59; 454.64); p < 0.00001). Lactate dehydrogenase (LDH) > 280 IU/L and creatinine kinase > 192 IU/L were parameters with a good area under the curve (0.804-LDH) and a positive predictive value (42.9%-CK). The clinical course of COVID-19 was mild to moderate in most patients. Children with comorbidities, dyspnea, or abnormalities on auscultation are at risk of oxygen therapy. Laboratory parameters potentially useful in patients evaluated for the severe course are LDH > 200 IU/L and CK > 192 IU/L.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje